Published in J Vasc Surg on December 01, 2007
Arsenic requires sphingosine-1-phosphate type 1 receptors to induce angiogenic genes and endothelial cell remodeling. Am J Pathol (2009) 1.01
Phospholipases of mineralization competent cells and matrix vesicles: roles in physiological and pathological mineralizations. Int J Mol Sci (2013) 0.84
Mechanisms of sphingosine-1-phosphate-induced akt-dependent smooth muscle cell migration. Surgery (2008) 0.78
Urokinase requires NAD(P)H oxidase to transactivate the epidermal growth factor receptor. Surgery (2012) 0.77
SRC regulates sphingosine-1-phosphate mediated smooth muscle cell migration. J Surg Res (2011) 0.77
Role of S-1-P receptors and human vascular smooth muscle cell migration in diabetes and metabolic syndrome. J Surg Res (2012) 0.77
Vascular NAD(P)H oxidases: specific features, expression, and regulation. Am J Physiol Regul Integr Comp Physiol (2003) 3.63
Angiotensin II stimulation of NAD(P)H oxidase activity: upstream mediators. Circ Res (2002) 3.32
Role of the sphingosine-1-phosphate receptor EDG-1 in PDGF-induced cell motility. Science (2001) 2.17
Differential coupling of the sphingosine 1-phosphate receptors Edg-1, Edg-3, and H218/Edg-5 to the G(i), G(q), and G(12) families of heterotrimeric G proteins. J Biol Chem (1999) 1.90
Increased NAD(P)H oxidase and reactive oxygen species in coronary arteries after balloon injury. Arterioscler Thromb Vasc Biol (2001) 1.86
Sphingosine-1 phosphate prevents monocyte/endothelial interactions in type 1 diabetic NOD mice through activation of the S1P1 receptor. Circ Res (2006) 1.81
Pathobiology of intimal hyperplasia. Br J Surg (1994) 1.74
A unique fold of phospholipase C-beta mediates dimerization and interaction with G alpha q. Nat Struct Biol (2002) 1.23
Distinctive G protein-dependent signaling in smooth muscle by sphingosine 1-phosphate receptors S1P1 and S1P2. Am J Physiol Cell Physiol (2004) 1.15
Sphingosine kinase functionally links elevated transmural pressure and increased reactive oxygen species formation in resistance arteries. FASEB J (2006) 1.14
Domain-dependent action of urokinase on smooth muscle cell responses. J Vasc Surg (2004) 1.08
Vascular oxidant stress early after balloon injury: evidence for increased NAD(P)H oxidoreductase activity. Free Radic Biol Med (2000) 1.05
Involvement of pertussis toxin-sensitive GTP-binding proteins in sphingosine 1-phosphate-induced activation of phospholipase C-Ca2+ system in HL60 leukemia cells. FEBS Lett (1996) 1.02
The sphingomyelin/ceramide pathway is involved in ERK1/2 phosphorylation, cell proliferation, and uPAR overexpression induced by tissue-type plasminogen activator. FASEB J (2004) 1.02
Sphingosine-1-phosphate-induced smooth muscle cell migration involves the mammalian target of rapamycin. J Vasc Surg (2005) 1.01
Sphingosine 1-phosphate stimulates hydrogen peroxide generation through activation of phospholipase C-Ca2+ system in FRTL-5 thyroid cells: possible involvement of guanosine triphosphate-binding proteins in the lipid signaling. Endocrinology (1997) 0.98
Subtype-specific, differential activities of the EDG family receptors for sphingosine-1-phosphate, a novel lysophospholipid mediator. Mol Cell Endocrinol (2001) 0.95
Sphingosine-1-phosphate induces G(alphai)-coupled, PI3K/ras-dependent smooth muscle cell migration. J Surg Res (2002) 0.93
Sphingosine-1-phosphate stimulates smooth muscle cell migration through galpha(i)- and pi3-kinase-dependent p38(MAPK) activation. J Surg Res (2003) 0.90
Platelet-derived growth factor (PDGF)-induced chemotaxis does not require the G protein-coupled receptor S1P1 in murine embryonic fibroblasts and vascular smooth muscle cells. FEBS Lett (2003) 0.89
G proteins in signal transduction: the regulation of phospholipase C. Ciba Found Symp (1993) 0.87
Characterization of S1P1 and S1P2 receptor function in smooth muscle by receptor silencing and receptor protection. Am J Physiol Gastrointest Liver Physiol (2006) 0.86
Angiotensin II activates the beta 1 isoform of phospholipase C in vascular smooth muscle cells. Am J Physiol (1997) 0.82
Role of Galphaq in smooth muscle cell proliferation. J Vasc Surg (2004) 0.80
Angiotensin II-induced MAPK phosphorylation mediated by Ras and/or phospholipase C-dependent phosphorylations but not by protein kinase C phosphorylation in cultured rat vascular smooth muscle cells. Pharmacology (2006) 0.78
[Roles of Galphaq/11 mediated- and platelet-derived growth factor mediated-signal transduction pathways in rat aorta restenosis]. Sheng Li Xue Bao (2001) 0.77
Pseudoaneurysms and the role of minimally invasive techniques in their management. Radiographics (2005) 3.76
Percutaneous angioplasty and stenting of the superficial femoral artery. J Vasc Surg (2005) 1.77
Impact of diabetes mellitus on outcomes of superficial femoral artery endoluminal interventions. J Vasc Surg (2007) 1.75
Hemodynamic benefits of regional anesthesia for carotid endarterectomy. J Vasc Surg (2002) 1.61
Influence of chronic renal insufficiency on outcomes following carotid revascularization. Arch Surg (2011) 1.53
Catheter thrombolysis of thrombosed hepatic arteries in liver transplant recipients: predictors of success and role of thrombolysis. Vasc Endovascular Surg (2007) 1.47
Current efficacy of open and endovascular interventions for advanced superficial femoral artery occlusive disease. J Vasc Surg (2013) 1.43
Arc of buhler: incidence and diameter in asymptomatic individuals. Vasc Endovascular Surg (2005) 1.42
Vascular biology of metabolic syndrome. J Vasc Surg (2011) 1.21
Skeletal muscle BOLD MRI: from underlying physiological concepts to its usefulness in clinical conditions. J Magn Reson Imaging (2012) 1.10
Domain-dependent action of urokinase on smooth muscle cell responses. J Vasc Surg (2004) 1.08
Rotational muscle flap closure for acute groin wound infections following vascular surgery. Ann Vasc Surg (2004) 1.06
Long-term outcomes of catheter directed thrombolysis for lower extremity deep venous thrombosis without prophylactic inferior vena cava filter placement. J Vasc Surg (2007) 1.02
Plasminogen activator system and vascular disease. Curr Vasc Pharmacol (2006) 1.02
Urokinase-induced smooth muscle cell responses require distinct signaling pathways: a role for the epidermal growth factor receptor. J Vasc Surg (2005) 1.02
Balloon-occlusion catheter rupture during balloon-occluded retrograde transvenous obliteration of gastric varices utilizing sodium tetradecyl sulfate: incidence and consequences. Vasc Endovascular Surg (2012) 1.01
Sphingosine-1-phosphate-induced smooth muscle cell migration involves the mammalian target of rapamycin. J Vasc Surg (2005) 1.01
Flow-induced neointimal regression in baboon polytetrafluoroethylene grafts is associated with decreased cell proliferation and increased apoptosis. J Vasc Surg (2002) 1.00
Long-term outcomes of primary angioplasty and primary stenting of central venous stenosis in hemodialysis patients. J Vasc Surg (2007) 0.99
Influence of LVAD cannula outflow tract location on hemodynamics in the ascending aorta: a patient-specific computational fluid dynamics approach. ASAIO J (2012) 0.97
Percutaneous transluminal revascularization for iliac occlusive disease: long-term outcomes in TransAtlantic Inter-Society Consensus A and B lesions. Ann Vasc Surg (2005) 0.96
Management of effort thrombosis of the subclavian vein: today's treatment. Ann Vasc Surg (2007) 0.94
Increased plasmin and serine proteinase activity during flow-induced intimal atrophy in baboon PTFE grafts. Arterioscler Thromb Vasc Biol (2002) 0.94
Hybrid thoracic endovascular aortic repair: pushing the envelope. J Vasc Surg (2009) 0.94
Sphingosine-1-phosphate induces G(alphai)-coupled, PI3K/ras-dependent smooth muscle cell migration. J Surg Res (2002) 0.93
Radiation arteritis: a contraindication to carotid stenting? J Vasc Surg (2007) 0.92
Efficacy of covered stent placement for central venous occlusive disease in hemodialysis patients. J Vasc Surg (2011) 0.92
Urokinase-induced smooth muscle cell migration requires PI3-K and Akt activation. J Surg Res (2005) 0.92
Outcome after autogenous brachial-basilic upper arm transpositions in the post-National Kidney Foundation Dialysis Outcomes Quality Initiative era. J Vasc Surg (2005) 0.91
Protective value of TIPS against the development of hydrothorax/ascites and upper gastrointestinal bleeding after balloon-occluded retrograde transvenous obliteration (BRTO). Am J Gastroenterol (2013) 0.90
Long-term outcomes of endoluminal therapy for chronic atherosclerotic occlusive mesenteric disease. Ann Vasc Surg (2008) 0.90
Feasibility of simultaneous pre- and postfilter transcranial Doppler monitoring during carotid artery stenting. J Vasc Surg (2009) 0.90
Is there a selection bias in applying endovascular aneurysm repair for rupture? Ann Vasc Surg (2008) 0.90
Sphingosine-1-phosphate stimulates smooth muscle cell migration through galpha(i)- and pi3-kinase-dependent p38(MAPK) activation. J Surg Res (2003) 0.90
Prevalence of variant brachial-basilic vein anatomy and implications for vascular access planning. J Vasc Surg (2010) 0.90
Management of bleeding after percutaneous transhepatic cholangiography or transhepatic biliary drain placement. Tech Vasc Interv Radiol (2008) 0.90
Hepatic artery stenosis in liver transplant recipients: primary treatment with percutaneous transluminal angioplasty. J Vasc Interv Radiol (2005) 0.90
Computational hemodynamics in the human aorta: a computational fluid dynamics study of three cases with patient-specific geometries and inflow rates. Technol Health Care (2008) 0.89
Metabolic syndrome: A predictor of adverse outcomes after carotid revascularization. J Vasc Surg (2009) 0.89
Patterns of kinase activation induced by injury in the murine femoral artery. J Surg Res (2007) 0.89
Medical and endovascular management of critical limb ischemia. J Endovasc Ther (2009) 0.89
Hemodynamics of distal revascularization-interval ligation. Ann Vasc Surg (2005) 0.89
Blood oxygenation level-dependent (BOLD) MRI of human skeletal muscle at 1.5 and 3 T. J Magn Reson Imaging (2012) 0.88
Hybrid debranching-endovascular repair of visceral patch aneurysm after thoracoabdominal aneurysm repair. Vasc Endovascular Surg (2007) 0.88
Differential regulation of ERK1/2 and p38(MAPK) by components of the Rho signaling pathway during sphingosine-1-phosphate-induced smooth muscle cell migration. J Surg Res (2004) 0.88
Longitudinal computational fluid dynamics study of aneurysmal dilatation in a chronic DeBakey type III aortic dissection. J Vasc Surg (2012) 0.88
Use of computer simulation for determining endovascular skill levels in a carotid stenting model. J Vasc Surg (2004) 0.88
Patterns of gelatinase activation induced by injury in the murine femoral artery. J Surg Res (2008) 0.87
Management of vascular and nonvascular complications after renal transplantation. Tech Vasc Interv Radiol (2009) 0.87
Transhepatic hemodialysis catheters: functional outcome and comparison between early and late failure. J Vasc Interv Radiol (2011) 0.86
Impact of tear location on hemodynamics in a type B aortic dissection investigated with computational fluid dynamics. Conf Proc IEEE Eng Med Biol Soc (2010) 0.86
Cell migration in response to the amino-terminal fragment of urokinase requires epidermal growth factor receptor activation through an ADAM-mediated mechanism. J Vasc Surg (2009) 0.86
Hybrid thoracic endovascular aortic repair via right anterior minithoracotomy. J Thorac Cardiovasc Surg (2011) 0.86
Stent-grafts for transjugular intrahepatic portosystemic shunt creation: specialized TIPS stent-graft versus generic stent-graft/bare stent combination. J Vasc Interv Radiol (2010) 0.86
Spontaneous regression of an abdominal aortic aneurysm in an immunocompromised patient. Vasc Med (2010) 0.85
Implications of early failure of superficial femoral artery endoluminal interventions. Ann Vasc Surg (2005) 0.85
Endoluminal management of arterioportal fistulae in liver transplant recipients: a single-center experience. Vasc Endovascular Surg (2007) 0.84
Concomitant reconstruction of infrarenal aorta and inferior vena cava after en bloc resection of retroperitoneal rhabdomyosarcoma. Vasc Endovascular Surg (2011) 0.84
Plasmin induces smooth muscle cell proliferation. J Surg Res (2005) 0.84
A computational fluid dynamics study pre- and post-stent graft placement in an acute type B aortic dissection. Vasc Endovascular Surg (2010) 0.84
Increasing dialysis access options in lower extremity: retroperitoneal approach for external iliac artery-vein arteriovenous graft. J Vasc Access (2011) 0.84
Inadvertent discontinuation of percutaneous nephrostomy catheters in adult native kidneys: incidence and percutaneous management. J Vasc Interv Radiol (2006) 0.84
Endovascular management of central venous stenoses in the hemodialysis patient: results of percutaneous therapy. Vasc Endovascular Surg (2004) 0.84
Subclavian artery revascularization: an outcome analysis based on mode of therapy and presenting symptoms. Ann Vasc Surg (2008) 0.83
Percutaneous therapy for renal artery fibromuscular dysplasia. Ann Vasc Surg (2003) 0.83
Impact of metabolic syndrome on the outcomes of superficial femoral artery interventions. J Vasc Surg (2012) 0.83
Transhepatic dilation of anastomotic biliary strictures in liver transplant recipients with use of a combined cutting and conventional balloon protocol: technical safety and efficacy. J Vasc Interv Radiol (2006) 0.83
Transjugular intrahepatic portosystemic shunts in liver transplant recipients: technical analysis and clinical outcome. AJR Am J Roentgenol (2013) 0.83
Regional quality groups in the Society for Vascular Surgery® Vascular Quality Initiative. J Vasc Surg (2013) 0.83
Extrahepatic pseudoaneurysms and ruptures of the hepatic artery in liver transplant recipients: endovascular management and a new iatrogenic etiology. Cardiovasc Intervent Radiol (2012) 0.83
Plasmin-induced smooth muscle cell proliferation requires epidermal growth factor activation through an extracellular pathway. Surgery (2005) 0.82
Role for Gβγ G-proteins in protease regulation during remodeling of the murine femoral artery. J Surg Res (2011) 0.82
Incidence of cholangitis and sepsis associated with percutaneous transhepatic biliary drain cholangiography and exchange: a comparison between liver transplant and native liver patients. AJR Am J Roentgenol (2011) 0.82
Transjugular intrahepatic portosystemic shunt in a living donor left lateral segment liver transplant recipient: technical considerations. J Vasc Interv Radiol (2005) 0.81
Glucocorticoid-regulated VEGF expression in ischemic skeletal muscle. Mol Ther (2002) 0.81
Popliteal-to-distal bypass: identifying risk factors associated with limb loss and graft failure. Vasc Endovascular Surg (2005) 0.81
Integration of the computational fluid dynamics technique with MRI in aortic dissections. Magn Reson Med (2012) 0.81
Gαq G proteins modulate MMP-9 gelatinase during remodeling of the murine femoral artery. J Surg Res (2012) 0.80
Incorporating simulation in vascular surgery education. J Vasc Surg (2010) 0.80
Systemic basic fibroblast growth factor induces favorable histological changes in the corpus cavernosum of hypercholesterolemic rabbits. J Urol (2003) 0.80
Robot-assisted stenting of a high-grade anastomotic pulmonary artery stenosis following single lung transplantation. J Endovasc Ther (2010) 0.80
Hybrid approach for removal of an errant intra-vascular pedicle spinal fixation screw in the thoracic aorta. J Vasc Surg (2012) 0.80
Role of Galphaq in smooth muscle cell proliferation. J Vasc Surg (2004) 0.80
The effect of balloon-occluded transvenous obliteration of gastric varices and gastrorenal shunts on the hepatic synthetic function: a comparison between Child-Pugh and model for end-stage liver disease scores. Vasc Endovascular Surg (2013) 0.80
Incidence of arterial injuries detected by arteriography following percutaneous right-lobe ultrasound-guided core liver biopsies in human subjects. Am J Gastroenterol (2006) 0.80
Percutaneous and open renal revascularizations have equivalent long-term functional outcomes. Ann Vasc Surg (2005) 0.80
Volume Flow Measurements in Arteriovenous Dialysis Access in Patients with and without Steal Syndrome. Int J Vasc Med (2013) 0.80
Surgical management of hemodialysis-related central venous occlusive disease: a treatment algorithm. Ann Vasc Surg (2011) 0.79
Combined femoral vein transposition and iliac vein to suprarenal vena cava bypass as a last resort dialysis access. Ann Vasc Surg (2010) 0.79
Preliminary findings in quantification of changes in septal motion during follow-up of type B aortic dissections. J Vasc Surg (2012) 0.79
Elective transjugular intrahepatic portosystemic shunt creation for portal decompression in the immediate pretransplantation period in adult living related liver transplant recipient candidates: preliminary results. J Vasc Interv Radiol (2006) 0.79
EEG changes during awake carotid endarterectomy. Ann Vasc Surg (2002) 0.79
Detection of adventitial vasa vasorum and intraplaque neovascularization in carotid atherosclerotic lesions with contrast-enhanced ultrasound and their role in atherosclerosis. Methodist Debakey Cardiovasc J (2011) 0.78
Transhepatic balloon dilation of anastomotic biliary strictures in liver transplant recipients: the significance of a patent hepatic artery. J Vasc Interv Radiol (2005) 0.78